Indian Journal of Urology Users online:2012  
Home Current Issue Ahead of print Editorial Board Archives Symposia Guidelines Subscriptions Login 
Print this page  Email this page Small font sizeDefault font sizeIncrease font size

    Article Cited by others


Refractory overactive bladder: Beyond oral anticholinergic therapy

Glinski Ronald W, Siegel Steven

Year : 2007| Volume: 23| Issue : 2 | Page no: 166-173

   This article has been cited by
1 Clinical direction in the pharmacological and device management of refractory overactive bladder: the urge to develop new treatments
David Staskin
Expert Opinion on Pharmacotherapy. 2022; : 1
[Pubmed]  [Google Scholar] [DOI]
2 Sacral neuromodulation for the treatment of overactive bladder: systematic review and future prospects
Sam Tilborghs, Stefan De Wachter
Expert Review of Medical Devices. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Solifenacin succinate versus percutaneous tibial nerve stimulation in women with overactive bladder syndrome: Results of a randomized controlled crossover study
Vecchioli-Scaldazza, C. and Morosetti, C. and Berouz, A. and Giannubilo, W. and Ferrara, V.
Gynecologic and Obstetric Investigation. 2013; 75(4): 230-234
[Pubmed]  [Google Scholar]
4 Solifenacin Succinate versus Percutaneous Tibial Nerve Stimulation in Women with Overactive Bladder Syndrome: Results of a Randomized Controlled Crossover Study
Carlo Vecchioli-Scaldazza, Carolina Morosetti, Azizi Berouz, Willy Giannubilo, Vincenzo Ferrara
Gynecologic and Obstetric Investigation. 2013; 75(4): 230
[Pubmed]  [Google Scholar] [DOI]
5 Voiding dysfunction in the female patient: Is the "syndrome" paradigm valid?
Tunuguntla, H.S.G.R. and Tunuguntla, R. and Barone, J. and Kanagarajah, P. and Gousse, A.E.
Current Urology Reports. 2011; 12(5): 377-380
[Pubmed]  [Google Scholar]
6 Repeat intradetrusor injections of onabotulinum toxin A for refractory idiopathic overactive bladder patients: A single-center experience
Gousse, A.E. and Kanagarajah, P. and Ayyathurai, R. and Handa, P. and Dabas, N. and Gomez, C.S.
Female Pelvic Medicine and Reconstructive Surgery. 2011; 17(5): 253-257
[Pubmed]  [Google Scholar]
7 Voiding Dysfunction in the Female Patient: Is the “Syndrome” Paradigm Valid?
Hari Siva G. R. Tunuguntla,Renuka Tunuguntla,Joseph Barone,Prashanth Kanagarajah,Angelo E. Gousse
Current Urology Reports. 2011; 12(5): 377
[Pubmed]  [Google Scholar] [DOI]
8 Repeat Intradetrusor Injections of Onabotulinum Toxin A for Refractory Idiopathic Overactive Bladder Patients
Angelo E. Gousse, Prashanth Kanagarajah, Rajinikanth Ayyathurai, Priyanka Handa, Nikita Dabas, Christopher S. Gomez
Female Pelvic Medicine & Reconstructive Surgery. 2011; 17(5): 253
[Pubmed]  [Google Scholar] [DOI]
9 Overactive Bladder Syndrome
Oroma B. Nwanodi,Gil Levy
Postgraduate Obstetrics & Gynecology. 2010; 30(12): 1
[Pubmed]  [Google Scholar] [DOI]
10 Sacral neuromodulation: Therapy evolution
Thompson, J.H. and Sutherland, S.E. and Siegel, S.W.
Indian Journal of Urology. 2010; 26(3): 379-384
[Pubmed]  [Google Scholar]
11 Lower Urinary Tract Symptoms: Defining Syndromes in Urology
Prashanth Kanagarajah, Rajinikanth Ayyathurai, Angelo E. Gousse
Current Bladder Dysfunction Reports. 2010; 5(4): 233
[HTML Full text]  [Google Scholar] [DOI]


Read this article